Evidence map›Paper›PMID 18650482›Full record

ArticleJournal of the American Society of Nephrology : JASN2008

Inhibition of SNAT2 by metabolic acidosis enhances proteolysis in skeletal muscle.

Kate Evans, Zeerak Nasim, Jeremy Brown, Emma Clapp, Amin Amin, Bin Yang, Terence P Herbert, Alan Bevington

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kate EvansDepartment of Infection, Immunity and Inflammation, University of Leicester, John Walls Renal Unit, Leicester General Hospital, Leicester LE5 4PW, UK.
Zeerak Nasim
Jeremy Brown
Emma Clapp
Amin Amin
Bin Yang
Terence P Herbert
Alan Bevington
University of Leicester · GBLeicester General Hospital · GBLoughborough University · GB

Funding

Wellcome TrustWellcome Trust 059828/Z/99/Z
6 · The paper itself

Abstract

Insulin resistance is a major cause of muscle wasting in patients with ESRD. Uremic metabolic acidosis impairs insulin signaling, which normally suppresses proteolysis. The low pH may inhibit the SNAT2 l-Glutamine (L-Gln) transporter, which controls protein synthesis via amino acid-dependent insulin signaling through mammalian target of rapamycin (mTOR). Whether SNAT2 also regulates signaling to pathways that control proteolysis is unknown. In this study, inhibition of SNAT2 with the selective competitive substrate methylaminoisobutyrate or metabolic acidosis (pH 7.1) depleted intracellular L-Gln and stimulated proteolysis in cultured L6 myotubes. At pH 7.1, inhibition of the proteasome led to greater depletion of L-Gln, indicating that amino acids liberated by proteolysis sustain L-Gln levels when SNAT2 is inhibited by acidosis. Acidosis shifted the dose-response curve for suppression of proteolysis by insulin to the right, confirming that acid increases proteolysis by inducing insulin resistance. Blocking mTOR or phosphatidylinositol-3-kinase (PI3K) increased proteolysis, indicating that both signaling pathways are involved in its regulation. When both mTOR and PI3K were inhibited, methylaminoisobutyrate or acidosis did not stimulate proteolysis further. Moreover, partial silencing of SNAT2 expression in myotubes and myoblasts with small interfering RNA stimulated proteolysis and impaired insulin signaling through PI3K. In conclusion, SNAT2 not only regulates mTOR but also regulates proteolysis through PI3K and provides a link among acidosis, insulin resistance, and protein wasting in skeletal muscle cells.

Indexed as

AcidosisAmino Acid Transport System AAnimalsBase SequenceCarrier ProteinsCell LineGlutamineHumansHydrogen-Ion ConcentrationInsulin ResistanceMuscle, SkeletalMyoblasts, SkeletalPeptide HydrolasesPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Proto-Oncogene Proteins c-aktAmino Acid Transport System ACarrier ProteinsGlutamineMTOR protein, humanmTOR protein, mousePeptide HydrolasesPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Proto-Oncogene Proteins c-aktRNA, Small InterferingSlc38a2 protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID18650482
PMCPMC2573006
OpenAlexW2133907784

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.